Glenview Capital Management - Q2 2023 holdings

$4.44 Billion is the total value of Glenview Capital Management's 49 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 38.9% .

 Value Shares↓ Weighting
CI BuyTHE CIGNA GROUP$579,593,611
+22.6%
2,065,551
+11.6%
13.07%
+25.9%
SPY BuySPDR S&P 500 ETF TRput$531,936,000
+8.3%
1,200,000
+0.1%
11.99%
+11.3%
THC SellTENET HEALTHCARE CORP$526,430,781
+21.9%
6,468,798
-11.0%
11.87%
+25.3%
DXC BuyDXC TECHNOLOGY CO$260,103,462
+13.6%
9,734,411
+8.7%
5.86%
+16.7%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$222,538,529
+103.1%
1,410,525
+63.6%
5.02%
+108.7%
GPN  GLOBAL PMTS INC$221,096,022
-6.4%
2,244,1740.0%4.98%
-3.8%
CLVT BuyCLARIVATE PLC$165,016,191
+51.1%
17,315,445
+48.9%
3.72%
+55.3%
MCK SellMCKESSON CORP$161,605,651
-29.1%
378,193
-40.9%
3.64%
-27.1%
ALIT BuyALIGHT INC$139,498,063
+7.1%
15,097,193
+6.7%
3.14%
+10.0%
CTVA BuyCORTEVA INC$119,943,798
+21.3%
2,093,260
+27.7%
2.70%
+24.7%
IWM NewISHARES TRput$112,362,000600,000
+100.0%
2.53%
USFD SellUS FOODS HLDG CORP$112,347,576
-15.3%
2,553,354
-28.9%
2.53%
-13.0%
FISV SellFISERV INC$111,146,728
-54.3%
881,068
-59.0%
2.51%
-53.0%
VVV SellVALVOLINE INC$105,124,813
-20.9%
2,802,581
-26.3%
2.37%
-18.7%
FMC BuyFMC CORP$88,923,035
-9.3%
852,243
+6.2%
2.00%
-6.8%
MYGN SellMYRIAD GENETICS INC$86,806,504
-10.9%
3,744,888
-10.7%
1.96%
-8.5%
APTV SellAPTIV PLC$84,524,088
-19.2%
827,937
-11.3%
1.91%
-17.0%
HCA SellHCA HEALTHCARE INC$80,004,612
-32.9%
263,624
-41.7%
1.80%
-31.0%
BKD  BROOKDALE SR LIVING INC$78,680,520
+43.1%
18,644,6730.0%1.77%
+47.0%
DD SellDUPONT DE NEMOURS INC$74,454,768
-14.8%
1,042,200
-14.4%
1.68%
-12.4%
CI NewTHE CIGNA GROUPcall$68,606,700244,500
+100.0%
1.55%
UBER SellUBER TECHNOLOGIES INC$67,263,997
-28.7%
1,558,119
-47.7%
1.52%
-26.8%
ATVI SellACTIVISION BLIZZARD INC$57,648,471
-19.7%
683,849
-18.5%
1.30%
-17.5%
ESI SellELEMENT SOLUTIONS INC$48,895,085
-16.3%
2,546,619
-15.8%
1.10%
-14.0%
EXPE  EXPEDIA GROUP INC$41,900,527
+12.7%
383,0380.0%0.94%
+16.0%
SellEVOLV TECHNOLOGIES HLDNGS IN$28,975,170
+47.0%
4,829,195
-23.6%
0.65%
+51.2%
CAH BuyCARDINAL HEALTH INC$24,335,698
+128.5%
257,330
+82.5%
0.55%
+134.6%
FDX SellFEDEX CORP$23,706,181
-36.2%
95,628
-41.2%
0.53%
-34.5%
HPE NewHEWLETT PACKARD ENTERPRISE C$21,000,0001,250,000
+100.0%
0.47%
NewWARNER BROS DISCOVERY INC$20,368,7221,624,300
+100.0%
0.46%
 BROOKDALE SR LIVING INCnote 2.000%10/1$20,034,622
+10.1%
25,450,0000.0%0.45%
+13.3%
MTCH  MATCH GROUP INC NEW$19,873,979
+9.0%
474,8860.0%0.45%
+12.0%
BFLY  BUTTERFLY NETWORK INC$18,477,052
+22.3%
8,033,5010.0%0.42%
+26.0%
FLEX SellFLEX LTDord$17,188,183
-61.1%
621,859
-67.7%
0.39%
-60.1%
BHC NewBAUSCH HEALTH COS INC$14,131,1601,766,395
+100.0%
0.32%
AMZN SellAMAZON COM INC$13,038,216
-72.2%
100,017
-78.0%
0.29%
-71.5%
DMRC  DIGIMARC CORP NEW$12,791,592
+49.8%
434,4970.0%0.29%
+54.0%
UNP  UNION PAC CORP$12,789,568
+1.7%
62,5040.0%0.29%
+4.3%
CCEP SellCOCA-COLA EUROPACIFIC PARTNE$12,100,598
-83.0%
187,810
-84.4%
0.27%
-82.5%
CHTR NewCHARTER COMMUNICATIONS INC Ncl a$11,522,92731,366
+100.0%
0.26%
KNX SellKNIGHT-SWIFT TRANSN HLDGS INcl a$5,556,000
-73.9%
100,000
-73.4%
0.12%
-73.2%
QSI SellQUANTUM SI INC$4,324,622
-41.7%
2,415,990
-42.7%
0.10%
-40.5%
CANO BuyCANO HEALTH INC$2,363,177
+173.3%
1,700,127
+78.9%
0.05%
+178.9%
BLI  PHENOMEX INC$1,869,993
-57.8%
3,816,3130.0%0.04%
-56.7%
DNB  DUN & BRADSTREET HLDGS INC$1,786,107
-1.4%
154,3740.0%0.04%0.0%
BuyRAPID MICRO BIOSYSTEMS INC$1,318,288
+23.0%
1,318,288
+61.1%
0.03%
+25.0%
NewCIBUS INC$1,259,612119,963
+100.0%
0.03%
BFLYWS  BUTTERFLY NETWORK INC*w exp 02/12/202$403,490
-11.5%
1,713,3330.0%0.01%
-10.0%
NewDOMA HOLDINGS INC$98,77019,994
+100.0%
0.00%
ExitDOMA HOLDINGS INC$0-500,000
-100.0%
-0.00%
ANTM ExitELEVANCE HEALTH INC$0-11,867
-100.0%
-0.12%
SABR ExitSABRE CORP$0-2,200,398
-100.0%
-0.21%
WLTW ExitWILLIS TOWERS WATSON PLC LTD$0-46,541
-100.0%
-0.24%
LH ExitLABORATORY CORP AMER HLDGS$0-50,402
-100.0%
-0.25%
UNH ExitUNITEDHEALTH GROUP INC$0-36,716
-100.0%
-0.38%
DVA ExitDAVITA INC$0-276,175
-100.0%
-0.49%
GOOGL ExitALPHABET INCcap stk cl a$0-316,695
-100.0%
-0.72%
AVTR ExitAVANTOR INC$0-1,862,800
-100.0%
-0.86%
BABA ExitALIBABA GROUP HLDG LTDsponsored ads$0-403,063
-100.0%
-0.90%
ABC ExitAMERISOURCEBERGEN CORP$0-277,618
-100.0%
-0.98%
NSC ExitNORFOLK SOUTHN CORP$0-255,455
-100.0%
-1.19%
LII ExitLENNOX INTL INC$0-237,829
-100.0%
-1.31%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

About Glenview Capital Management

Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.

Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.

Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.

Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENET HEALTHCARE CORP42Q3 202316.7%
HCA HOLDINGS INC42Q3 20239.1%
MCKESSON CORP40Q3 20238.2%
FLEXTRONICS INTL LTD38Q2 20234.5%
BROOKDALE SR LIVING INC38Q3 20232.1%
MERITOR INC36Q1 20223.0%
FMC CORP34Q2 20236.4%
UNIVERSAL HLTH SVCS INC34Q3 20235.0%
HUMANA INC31Q4 202112.1%
ENDO INTL PLC30Q1 20222.8%

View Glenview Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Glenview Capital Management Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Butterfly Network, Inc.February 14, 20239,746,8345.5%
Quantum-Si IncFebruary 14, 20234,249,9563.6%
MERITOR, INC.February 22, 20223,544,3335.0%
ATI Physical Therapy, Inc.Sold outFebruary 14, 202200.0%
Evolv Technologies Holdings, Inc.February 14, 2022749,4610.5%
Velocity Acquisition Corp.Sold outFebruary 14, 202200.0%
Bausch Health Companies Inc.December 13, 202117,078,6574.8%
NewHold Investment Corp.June 04, 20211,114,8626.5%
Longview Acquisition Corp. IIApril 02, 20215,000,0007.2%
HighCape Capital Acquisition Corp.March 15, 20211,033,7398.7%

View Glenview Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-16
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14

View Glenview Capital Management's complete filings history.

Compare quarters

Export Glenview Capital Management's holdings